Hrt Financial LP Homology Medicines, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.39 - $3.12 $20,027 - $44,952	14,408 New	14,408 $28,000
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $120,944 - $193,975	-46,517 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $56,245 - $120,216	15,452 Added 49.74%	46,517 $169,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $186,700 - $270,576	31,065 New	31,065 $244,000
Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $137,109 - $221,289	-14,952 Closed	0 $0

Q4 2020 Feb 16, 2021	SELL	$8.92 - $13.29 $84,463 - $125,843	-9,469 Reduced 38.77%	14,952 $168,000
Q3 2020 Nov 13, 2020	BUY	$9.94 - $16.59 $242,744 - $405,144	24,421 New	24,421 $0

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.